BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, March 17, 2026

CMS

Home » Topics » Regulatory » CMS
  • Samsung bwell ehr 3 11 26
    March 17, 2026
    By Marian (YoonJee) Chu

    Samsung is adding trials and EHR access to Galaxy devices

    Samsung Electronics Co. Ltd. is partnering with Verily Life Sciences LLC, an Alphabet Inc. company, and B.well Connected Health to turn Samsung Galaxy phones and smart watches into the “front door” of U.S. health care.
  • Samsung bwell ehr 3 11 26
    March 11, 2026
    By Marian (YoonJee) Chu

    Samsung is adding trials and EHR access to Galaxy devices

    Samsung Electronics Co. Ltd. is partnering with Verily Life Sciences LLC, an Alphabet Inc. company, and B.well Connected Health to turn Samsung Galaxy phones and smart watches into the “front door” of U.S. health care.
  • March 9, 2026
    By Mari Serebrov

    Med-tech fraud charges lead to prison time

    Patrick Cassells, of Fulshear, Texas, was sentenced March 6 to more than seven years in prison and ordered to pay more than $25 million in restitution and forfeiture after he pleaded guilty nearly two years ago to one count of health care fraud that involved the three durable medical equipment companies he owned and operated.
Read More

Blog Posts

  • Nov. 25, 2014
    By Mark McCarty

    Thank you government!

  • Cms log blue2
    Dec. 12, 2012
    By Mark McCarty

    Meet the New CED

  • June 24, 2012
    By Mark McCarty

    The implications and future of TAVR

  • Feb. 29, 2012
    By Mark McCarty

    TAVR: What it says about FDA and CMS

  • Jan. 20, 2012
    By Holland Johnson

    J.P. Morgan healthcare meeting augurs trends for 2012 and beyond

Read More

Authors

  • Holland Johnson
  • Jim Stommen
  • Mark McCarty
  • Mari Serebrov
  • Meg Bryant
  • Stacy Lawrence
More Authors
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing